Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 7/20 | 0.37 |
| ▸ | MTNR1B | P49286 | 7/20 | 0.37 |
| ▸ | HTR1A | P08908 | 3/20 | 0.37 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29960516 | 0.79 | KCNH2 (0.44) | KCNH2MTNR1AMTNR1BHTR1AHTR2A | |
| SCHEMBL5231694 | 0.78 | MTNR1A (0.58) | MTNR1AMTNR1B | |
| SCHEMBL5175312 | 0.77 | KCNH2 (0.39) | KCNH2HTR1AHTR2ASSTR4 | |
| SCHEMBL27815888 | 0.77 | KCNH2 (0.42) | KCNH2MTNR1AMTNR1BHTR1AHTR2A | |
| SCHEMBL9692344 | 0.76 | SMN1; SMN2 (0.43) | KCNH2MTNR1AMTNR1BHTR1AHTR2A | |
| SCHEMBL9772853 | 0.75 | KCNH2 (0.44) | KCNH2HTR1AHTR2A | |
| SCHEMBL29960536 | 0.75 | KCNH2 (0.44) | KCNH2HTR1AHTR2A | |
| SCHEMBL29960346 | 0.75 | KCNH2 (0.44) | KCNH2MTNR1AMTNR1BHTR2ASSTR4 | |
| SCHEMBL5174865 | 0.75 | KCNH2 (0.44) | KCNH2MTNR1AMTNR1BHTR2ASSTR4 | |
| SCHEMBL8143471 | 0.74 | PPARD (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |